Fundraising Fox

Werewolf Therapeutics

Watertown, US · Founded 2017 · Delaware corporation · 6 known investors

Werewolf Therapeutics is a biotechnology company developing immunotherapy treatments for cancer. The company focuses on leveraging immune modulation and innovative therapeutic approaches in oncology.

Founders & leadership

Werewolf Therapeutics was founded in 2017 by Daniel J. Hicklin, Luke Evnin, and Daniel Hicklin.

DJ
Daniel J. HicklinFounder, President, Chief Executive Officer, and Board memberManaging Partner at MPM Capital
LELuke Evnin
Luke Evninin𝕏Co-founder, Board member (Chairman)Advisor at MPM BioImpact
DH
Daniel HicklinCo-founderManaging Partner at MPM Capital
DC
David CordoExecutive
AL
Alon LazarusNamed on SEC filing

Board

CWChristoph Westphal
Christoph WestphalBoard directorCo-Founder & General Partner at Longwood Fund
BMBriggs Morrison
Briggs MorrisoninBoard MemberEntrepreneur Partner at MPM BioImpact
SASakae Asanuma
Sakae AsanumaBoard directorPresident and CEO at Taiho Ventures, LLC

Investors · 6

Reported raises · per SEC filings

Form D private placements

$128.2M disclosed across 2 rounds · 2019–2020

$72.1MraisedJan 2021 · 19 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Luke EvninDirector
  • Briggs MorrisonDirector
  • Daniel HicklinExecutive Officer, Director
  • Sakae AsanumaDirector
  • Alon LazarusDirector
  • Elise WangDirector
  • David CordoExecutive Officer
  • Derek DiRoccoDirector
Offering amount
$72.1M
Amount sold
$72.1M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
$56.2MraisedAug 2020 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Luke EvninDirector
  • Daniel HicklinExecutive Officer, Director
  • Alon LazarusDirector
  • David CordoExecutive Officer
  • Christoph WestphalDirector
  • Briggs MorrisonDirector
  • Sakae AsanumaDirector
Offering amount
$56.2M
Amount sold
$56.2M
First sale
Aug 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through Werewolf Therapeutics went on to found or lead other companies.

Competitors · 5

by search overlap

Companies competing with Werewolf Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Werewolf Therapeutics do?
Werewolf Therapeutics is a biotechnology company developing immunotherapy treatments for cancer. The company focuses on leveraging immune modulation and innovative therapeutic approaches in oncology.
Who founded Werewolf Therapeutics?
Werewolf Therapeutics was founded by Daniel J. Hicklin, Luke Evnin, Daniel Hicklin in 2017.
Who are Werewolf Therapeutics's investors?
Werewolf Therapeutics's investors include DC Investment Partners, K2 HealthVentures, Longwood Fund, MPM BioImpact, RA Capital, Taiho Ventures, LLC.
How much funding has Werewolf Therapeutics raised?
Werewolf Therapeutics has disclosed $128.2M raised across 2 rounds.
Where is Werewolf Therapeutics headquartered?
Werewolf Therapeutics is headquartered in Watertown, US.